Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Risdiplam

🥰Excellent
Catalog No. T16757Cas No. 1825352-65-5
Alias RO7034067, RG7916

Risdiplam (RG7916) is a centrally and peripherally distributed and orally administrable small molecule SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels.

Risdiplam

Risdiplam

🥰Excellent
Purity: 99.43%
Catalog No. T16757Alias RO7034067, RG7916Cas No. 1825352-65-5
Risdiplam (RG7916) is a centrally and peripherally distributed and orally administrable small molecule SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels.
Pack SizePriceAvailabilityQuantity
1 mg52 €In Stock
2 mg76 €In Stock
5 mg122 €In Stock
10 mg200 €In Stock
25 mg357 €In Stock
50 mg531 €In Stock
100 mg746 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Risdiplam"

Select Batch
Purity:99.43%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Risdiplam (RG7916) is a centrally and peripherally distributed and orally administrable small molecule SMN2 pre-mRNA splicing modifier that increases survival motor neuron (SMN) protein levels.
In vitro
METHODS: LLC-PK1, MDCKII, L-MDR1 (LLC-PK1 cells transfected with human MDR1), L-Mdr1a (LLC-PK1 cells transfected with rodent Mdr1a), M-BCRP (MDCKII cells transfected with human breast cancer resistance protein; BCRP), and M-Bcrp1 (MDCKII cells transfected with rodent Bcrp1) cells were treated with Risdiplam (RG7916) (1 μM) and 10 μM Lucifer Yellow added to the donor compartment to initiate transcellular transport.
RESULTS Risdiplam had a mean passive permeability of approximately 350 nm/s in parental LLC-PK1 cells. Similar permeability was observed in L-MDR1, L-Mdra1, M-BCRP, and M-Bcrp cells in the presence of the inhibitor. [1]
In vivo
METHODS: Wistar rats received either a single oral dose of 14C-risdiplam (RO7034067) (by gastric gavage) or a single intravenous dose of 14C-risdiplam (by tail vein injection). Dose levels for oral and intravenous doses were 5 or 2 mg/kg, respectively.
RESULTS Radioactive 14C-risdiplam (RO7034067) was rapidly and extensively distributed in rat QWBA after oral administration, with peak concentrations in most tissues measured at 2 hours. Radioactivity concentrations in plasma and tissues declined during the study period. [1]
AliasRO7034067, RG7916
Chemical Properties
Molecular Weight401.46
FormulaC22H23N7O
Cas No.1825352-65-5
SmilesCc1cn2nc(cc(C)c2n1)-c1cc(=O)n2cc(ccc2n1)N1CCNC2(CC2)C1
Relative Density.1.50 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: < 1 mg/mL (insoluble), Sonication is recommended.
Ethanol: 2 mg/mL (4.98 mM), Sonication is recommended.
H2O: 2.22 mg/mL (5.53 mM), when pH is adjusted to 6 with HCl. Sonication is recommended.
Solution Preparation Table
Ethanol/H2O
1mg5mg10mg50mg
1 mM2.4909 mL12.4545 mL24.9091 mL124.5454 mL
H2O
1mg5mg10mg50mg
5 mM0.4982 mL2.4909 mL4.9818 mL24.9091 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Risdiplam | purchase Risdiplam | Risdiplam cost | order Risdiplam | Risdiplam chemical structure | Risdiplam in vivo | Risdiplam in vitro | Risdiplam formula | Risdiplam molecular weight